136 related articles for article (PubMed ID: 17936576)
1. In vivo characterization of human APOA5 haplotypes.
Ahituv N; Akiyama J; Chapman-Helleboid A; Fruchart J; Pennacchio LA
Genomics; 2007 Dec; 90(6):674-9. PubMed ID: 17936576
[TBL] [Abstract][Full Text] [Related]
2. Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism.
Henneman P; Schaap FG; Havekes LM; Rensen PC; Frants RR; van Tol A; Hattori H; Smelt AH; van Dijk KW
Atherosclerosis; 2007 Jul; 193(1):129-34. PubMed ID: 16777114
[TBL] [Abstract][Full Text] [Related]
3. The functional interaction on in vitro gene expression of APOA5 SNPs, defining haplotype APOA52, and their paradoxical association with plasma triglyceride but not plasma apoAV levels.
Palmen J; Smith AJ; Dorfmeister B; Putt W; Humphries SE; Talmud PJ
Biochim Biophys Acta; 2008; 1782(7-8):447-52. PubMed ID: 18395529
[TBL] [Abstract][Full Text] [Related]
4. [A novel gene in APOA1/C3/A4/A5 cluster: apolipoprotein A5].
Liu HK; Zhang SZ; Su ZG; Ma YX; Wang CT
Yi Chuan; 2004 Nov; 26(6):953-6. PubMed ID: 15640132
[TBL] [Abstract][Full Text] [Related]
5. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels.
Pennacchio LA; Olivier M; Hubacek JA; Krauss RM; Rubin EM; Cohen JC
Hum Mol Genet; 2002 Nov; 11(24):3031-8. PubMed ID: 12417524
[TBL] [Abstract][Full Text] [Related]
6. Efficient lowering of triglyceride levels in mice by human apoAV protein variants associated with hypertriglyceridemia.
Vaessen SF; Sierts JA; Kuivenhoven JA; Schaap FG
Biochem Biophys Res Commun; 2009 Feb; 379(2):542-6. PubMed ID: 19121291
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.
Hallman DM; Srinivasan SR; Chen W; Boerwinkle E; Berenson GS
Metabolism; 2006 Dec; 55(12):1574-81. PubMed ID: 17142127
[TBL] [Abstract][Full Text] [Related]
8. Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men.
Dallongeville J; Cottel D; Montaye M; Codron V; Amouyel P; Helbecque N
Int J Cardiol; 2006 Jan; 106(2):152-6. PubMed ID: 16321685
[TBL] [Abstract][Full Text] [Related]
9. Rare APOA5 mutations--clinical consequences, metabolic and functional effects: an ENID review.
Talmud PJ
Atherosclerosis; 2007 Oct; 194(2):287-92. PubMed ID: 17222847
[TBL] [Abstract][Full Text] [Related]
10. DNA polymorphisms and haplotypes of apolipoprotein A5's attribution to the plasma triglyceride levels in Koreans.
Choi JR; Nam CM; Kang DR; Eom SM; Lee HJ; Park CM; Im JW; Jang Y
Yonsei Med J; 2007 Aug; 48(4):609-18. PubMed ID: 17722232
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice.
Pennacchio LA; Rubin EM
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):529-34. PubMed ID: 12615678
[TBL] [Abstract][Full Text] [Related]
12. SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population.
Wright WT; Young IS; Nicholls DP; Patterson C; Lyttle K; Graham CA
Atherosclerosis; 2006 Apr; 185(2):353-60. PubMed ID: 16125709
[TBL] [Abstract][Full Text] [Related]
13. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides.
Talmud PJ; Hawe E; Martin S; Olivier M; Miller GJ; Rubin EM; Pennacchio LA; Humphries SE
Hum Mol Genet; 2002 Nov; 11(24):3039-46. PubMed ID: 12417525
[TBL] [Abstract][Full Text] [Related]
14. Haplotype analysis of the apolipoprotein A5 gene in obese pediatric patients.
Horvatovich K; Bokor S; Baráth A; Maász A; Kisfali P; Járomi L; Polgár N; Tóth D; Répásy J; Endreffy E; Molnár D; Melegh B
Int J Pediatr Obes; 2011 Jun; 6(2-2):e318-25. PubMed ID: 20883102
[TBL] [Abstract][Full Text] [Related]
15. Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia.
van der Vleuten GM; Isaacs A; Zeng WW; ter Avest E; Talmud PJ; Dallinga-Thie GM; van Duijn CM; Stalenhoef AF; de Graaf J
Biochim Biophys Acta; 2007 Jan; 1772(1):81-8. PubMed ID: 17157483
[TBL] [Abstract][Full Text] [Related]
16. Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia.
Mar R; Pajukanta P; Allayee H; Groenendijk M; Dallinga-Thie G; Krauss RM; Sinsheimer JS; Cantor RM; de Bruin TW; Lusis AJ
Circ Res; 2004 Apr; 94(7):993-9. PubMed ID: 15001527
[TBL] [Abstract][Full Text] [Related]
17. Haplotype analysis of the apolipoprotein A5 gene in patients with the metabolic syndrome.
Kisfali P; Mohás M; Maász A; Polgár N; Hadarits F; Markó L; Brasnyó P; Horvatovich K; Oroszlán T; Bagosi Z; Bujtor Z; Gasztonyi B; Rinfel J; Wittmann I; Melegh B
Nutr Metab Cardiovasc Dis; 2010 Sep; 20(7):505-11. PubMed ID: 19692219
[TBL] [Abstract][Full Text] [Related]
18. The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.
Martinelli N; Trabetti E; Bassi A; Girelli D; Friso S; Pizzolo F; Sandri M; Malerba G; Pignatti PF; Corrocher R; Olivieri O
Atherosclerosis; 2007 Apr; 191(2):409-17. PubMed ID: 16682041
[TBL] [Abstract][Full Text] [Related]
19. Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes.
Qi L; Liu S; Rifai N; Hunter D; Hu FB
Atherosclerosis; 2007 May; 192(1):204-10. PubMed ID: 16781717
[TBL] [Abstract][Full Text] [Related]
20. Different effects of apolipoprotein A5 SNPs and haplotypes on triglyceride concentration in three ethnic origins.
Ken-Dror G; Goldbourt U; Dankner R
J Hum Genet; 2010 May; 55(5):300-7. PubMed ID: 20395964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
